Invitae

Invitae Receivables/Revenue

Delisted

The Receivables to Revenue Ratio of Invitae (NVTAQ) as of Nov 4, 2026 is 18.61 %. In the previous year, Receivables to Revenue Ratio was 14.38 % — a change of 29.46% (higher).

Receivables/Revenue

18.61 %

YoY

29.46%

Last updated:

Receivables to Revenue Ratio of Invitae is 2022 18.61 % . Receivables to Revenue Ratio of Invitae was 2021 14.38 % . It decreases by 29.46% higher compared to the previous year.

The Invitae Receivables/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables/Revenue
Date
Receivables/Revenue
Jan 1, 2017
15.24 USD
Jan 1, 2018
17.81 USD
Jan 1, 2019
14.99 USD
Jan 1, 2020
17.06 USD
Jan 1, 2021
14.38 USD
Jan 1, 2022
18.61 USD
The Invitae Receivables/Revenue history
YEARReceivables/RevenueYoY
18.61 %+29.46%
14.38 %-15.73%
17.06 %+13.82%
14.99 %-15.82%
17.81 %+16.81%
15.24 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Invitae Stock analysis

What does Invitae do? Invitae Corp is a US-based company specialized in providing genetic tests for the diagnosis, treatment, and prevention of diseases. It was founded in 2010 and is headquartered in San Francisco, California. The company's goal is to lower the cost of genetic testing and increase accessibility for patients through automation and sample pooling methods. Invitae has received significant funding and has expanded its capital through multiple rounds of investments from venture capital firms, totaling nearly half a billion dollars. Its business model focuses on offering genetic tests to a wide range of patient groups, streamlining the testing processes through automation and software optimization. Invitae serves consumers directly, as well as medical professionals, hospitals, health centers, laboratories, and health insurance companies. The company aims to improve disease diagnosis and early detection while promoting long-term patient health. Invitae has broadened its capabilities through strategic acquisitions and partnerships, consolidating genetic data on a single platform. It offers a diverse portfolio of genetic tests for the diagnosis, treatment, and prevention of various diseases, including cancer predisposition, cardiovascular diseases, rare inherited diseases, neurological disorders, and medical genomics. The company also provides genetic counseling and family-oriented diagnosis services, along with an online platform facilitating interactive communication between doctors and patients, enabling the sharing and presentation of genetic information and test results. Invitae is an innovative company that has established itself as a market leader in genetic testing, offering a wide range of products and services facilitated by advanced technologies and data storage solutions. The recent acquisitions and partnerships have expanded Invitae's portfolio, improved its technology platform, and strengthened its position as a provider of high-quality healthcare services, enabling well-informed decision-making for patients and medical professionals. Invitae is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Invitae stock

Receivables to Revenue Ratio of Invitae is 18.61 % in 2022.

Receivables to Revenue Ratio of Invitae changed from 14.38 % to 18.61 %, representing a 29.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Receivables to Revenue Ratio Invitae since 2006 – with annual values, charts, and detailed analysis.

The Receivables/Revenue ratio shows what percentage of annual revenue is tied up in accounts receivable. Rising ratios may signal collection issues.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Receivables to Revenue Ratio's Invitae with sector peers and the industry average to assess whether it is attractive.

To evaluate Receivables to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Receivables to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Invitae

All Key Metrics — Invitae